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with degenerative encephalopathy, and indicated alteration of F1
biosynthesis [1]. The search in other cases for disease causing gene by
expression profiling and homozygosity mapping, identified mutation in
TMEM70 gene encoding a 30 kDa mitochondrial protein of unknown
function [2]. Enzyme defect was complemented by wtTMEM70 and
TMEM70protein turned out to be a novel ancillary factor of ATP synthase
biosynthesis, interestingly the first one specific for higher eukaryotes.
Homozygous TMEM70 c.317-2A>Gmutation leading to aberrant splicing
and loss of the TMEM70mRNAwas found in 24 patients, one patient was
compound heterozygote for c.118_119insGT frame-shift mutation. Since
then TMEM70mutations were found in other patients [3] thus being the
most frequent cause ofATP synthasedeficiency.Nevertheless, other cases
may exist where additional nuclear genes are involved.
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Autism is a severe pervasive developmental disorder characterized by
variable degrees of impairment in language, communication and social
skills, as well as by repetitive and stereotypic patterns of behaviour.
Despite strong familial components, clinical and genetic complexities
have posed a major challenge to our understanding of autism pathogen-
esis. A significant subset of autistic patients display biochemical or
neuropathological evidence of mitochondrial dysfunction and/or oxida-
tive stress. However, only in a very few cases abnormal energy
metabolism could be linked to a specific genetic defect. Interest in
assessing the role ofmitochondria in this disorder has been revitalized by
the association between autism and variants of the SLC25A12 gene [1],
which encodes the predominant isoform of themitochondrial aspartate/
glutamate carrier (AGC) in brain [2]. Cytosolic Ca2+ can rapidly activate
AGC transport through four “EF-hand”domains located at itsN-terminus,
thereby increasing the NADH/NAD ratio in themitochondrial matrix and
consequently boosting electron flow through the respiratory chain and
ATP generation by oxidative phosphorylation [3]. Post-mortem studies of
temporocortical gray matter from matched patient–control pairs
revealed that AGC transport rates were significantly higher in brains
from autistic patients [4]. This difference was blunted by Ca2+ chelator
EGTA and direct fluorimetric measurements confirmed significantly
higher Ca2+ levels in the patients, compared to their matched controls
[4]. Oxidized mitochondrial proteins were markedly increased in the
majority of the patients tested. Interestingly, oxidative damage correlated
with the reduction of complex I activity indicating that excessive Ca2+
levels boost AGC activity in neurons and, to amore variable degree, cause
oxidative stress and mitochondrial dysfunction in autistic brains.
Furthermore, we identified a protective SLC25A12 gene variant in a
sizable group of unaffected siblings modulating AGC1 mRNA levels and
protein activity. Our results suggest that mitochondria may play a critical
role in the cascade of signalling events leading to autism and in
determining to what extent different prenatal triggers will derange
neurodevelopment and yield abnormal postnatal behaviour.
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Heart failure is characterized by chronic, progressively worsening,
insufficient energy supply and failure of ventricular contraction for
the maintenance of blood circulation. We examined the abundance
and activity of crucial mitochondrial enzymes as potential contribu-
tors to heart failure. Human left ventricular tissue was biopsied from
non-failing donor hearts and end-stage failing hearts. Activity of
complexes I and IV, the NADH-linked Krebs enzymes isocitrate
dehydrogenase and malate dehydrogenase, NADPH transhydrogenase
and aconitase was lower in failing hearts, as determined spectro-
photometrically, while that of complexes II, III and citrate synthase
was unchanged. Specific protein expression of each of these,
determined by western blotting did not differ between the non-
failing and failing heart groups, implying post-translational protein
perturbation. Oxidative modification was explored as an underlying
cause of enzyme dysfunction. Of the three oxidative markers
measured, total mitochondrial protein carbonylation was greater by
31% in the failing tissues, while levels of 4-hydroxy-2-nonenal and
protein nitration did not differ. Isolation of complexes I, IV and V by
immunocapture revealed that subunits containing the iron–sulphur
or heme redox centers were targets of oxidative modification, which
may explain decreased activity in these enzymes. Notably the lower
level of mitochondrial activity in heart failure coincided with
significantly higher levels of oxidized glutathione, lower glutathione
reductase activity, and lower content of total Coenzyme Q10,
cardiolipin, total adenine nucleotides, NADH and NADPH. In conclu-
sion, the energy insufficiency of the failing human heart involves
impaired activity of key mitochondrial enzyme subunits, at least in
part due to oxidative modification. Thus the management of reactive
oxygen species which markedly deteriorates concomitant with
augmenting contractile failure may be a critical factor contributing
to spiralling energy deficiency in the failing human heart.
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Oxygen homeostasis is essential for normal cellular function; as
oxygen level decreases (hypoxia), cells respond by changing their
metabolism and by activating hypoxia-inducible factor dependent
gene transcription to adapt and survive. Mitochondria sense the
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